eMedicine World Medical Library

Excerpt from Wolff-Parkinson-White Syndrome


Synonyms, Key Words, and Related Terms: Wolff-Parkinson-White syndrome, preexcitation syndrome, atrioventricular reentrant tachycardia, AVRT, AVNRT, atrioventricular nodal reentrant tachycardia, AV nodal reentrant tachycardia, WPW syndrome, paroxysmal supraventricular tachycardia, PSVT, supraventricular tachycardia, SVT, heart disease

Please click here to view the full topic text: Wolff-Parkinson-White Syndrome

Background

Preexcitation was defined by Durrer et al in 1970 with the following statement, "Preexcitation exists, if in relation to atrial events, the whole or some part of the ventricular muscle is activated earlier by the impulse originating from the atrium than would be expected if the impulse reached the ventricles by way of the normal specific conduction system only."1 In preexcitation, atrial impulses bypass the typical electrical pathway that conducts via the atrioventricular node and activates the ventricular myocardium directly via an accessory pathway.  Of the various preexcitation syndromes, the most common is Wolff-Parkinson-White (WPW) syndrome. Emergency departments should be familiar with this syndrome and the proper treatment of its associated dysrhythmias to minimize morbidity and mortality.

For a CME activity, see Heart Healthy: Preventive Medicine 2008.

Pathophysiology

Accessory pathways or connections between the atrium and ventricle are the result of anomalous embryonic development of myocardial tissue bridging the fibrous tissues that separate the two chambers. This allows for electrical conduction between the atria and ventricles at sites other than the atrioventricular node (AVN). Passage through accessory pathways circumvent the usual conduction delay between the atria and ventricles, which normally occurs at the AVN and predisposes the patient to develop tachydysrhythmias.

Although dozens of locations for bypass tracts can exist in preexcitation, including atriofascicular, fasciculoventricular, intranodal, or nodoventricular, the most common bypass tract is an accessory atrioventricular (AV) pathway otherwise known as a Kent bundle. This is the anomaly seen in WPW syndrome. Conduction through a Kent bundle can be anterograde, retrograde, or both. Another common preexcitation syndrome, Lown-Ganong-Levine (LGL), also has an accessory pathway (the James fibers), which connect the atria serially to the His bundle. The end result is the same, preexcitation and a predisposition to the development of tachydysrhythmias. Fortunately, the treatment of LGL parallels that of WPW, and they are discussed together.

Frequency

International

WPW syndrome affects approximately 0.15-0.2% of the general population. Of these individuals, 60-70% have no other evidence of heart disease.

Mortality/Morbidity

Death from WPW syndrome occurs secondary to the associated dysrhythmias or from mistreatment of these dysrhythmias with inappropriate medications. Little data are available regarding the mortality rate of such dysrhythmias, but most studies report the incidence of sudden death in the 0-4% range.

Sex

Men (60-70% cases) are affected more often than women. Typically, those affected are young, otherwise healthy individuals.

Age

Although this disease affects people of all ages, it is most commonly recognized in children and young adults presenting to the ED with a dysrhythmia. Conduction speed in the accessory pathway appears to attenuate with age.

Please click here to view the full topic text: Wolff-Parkinson-White Syndrome

About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers
Labelled with ICRA © 1996-2006 by WebMD.
All Rights Reserved.

Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER